Frazier Life Sciences Public Fund, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO)

Reporting parties
Filing manager
Frazier Life Sciences Public Fund, L.P.
Reporting owner
Frazier Life Sciences Public Fund, L.P.
Subject security
Security
Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
LXEO
Shares outstanding
53,920,474 shares
Ownership signal
Disclosed shares
3,073,467 shares
Ownership percentage
5.7%
SEC evidence
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 13:40:44 UTC
Event date
30 Jun 2025
Previous filing
04 Jun 2025
Next filing
13 Feb 2026
SEC filing
View on sec.gov

Key filing fact

Frazier Life Sciences Public Fund, L.P. disclosed 5.7% ownership in Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO) on 30 Jun 2025.

Key facts

  • Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO).
  • Disclosed ownership: 5.7%.
  • Date of event: 30 Jun 2025.

Change

  • Previous schedule filing date: 04 Jun 2025.
  • Current filing was accepted on 14 Aug 2025, 13:40.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (20)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Frazier Life Sciences Public Fund, L.P. 5.7% 3,073,467 0 3,073,467 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
FHMLSP, L.P. 5.7% 3,073,467 0 3,073,467 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P.
FHMLSP, L.L.C. 5.7% 3,073,467 0 3,073,467 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C.
Frazier Life Sciences Public Overage Fund, L.P. 1.2% 624,804 0 624,804 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P., GP of Frazier Life Sciences Public Overage Fund, L.P.
FHMLSP Overage, L.P. 1.2% 624,804 0 624,804 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P.
FHMLSP Overage, L.L.C. 1.2% 624,804 0 624,804 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C.
Frazier Life Sciences X, L.P. 0.2% 87,424 0 87,424 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P.
FHMLS X, L.P. 0.2% 87,424 0 87,424 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P.
FHMLS X, L.L.C. 0.2% 87,424 0 87,424 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C.
Frazier Life Sciences XI, L.P. 0.4% 232,784 0 232,784 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P.
FHMLS XI, L.P. 0.4% 232,784 0 232,784 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P.
FHMLS XI, L.L.C. 0.4% 232,784 0 232,784 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C.
Frazier Life Sciences XII, L.P. 0.8% 406,246 0 406,246 /s/ Gordon Empey By Gordon Empey, General Counsel of FHMLS XII, L.L.C., GP of FHMLS XII, L.P., GP of Frazier Life Sciences XII, L.P.
FHMLS XII, L.P. 0.8% 406,246 0 406,246 /s/ Gordon Empey By Gordon Empey, General Counsel of FHMLS XII, L.L.C., GP of FHMLS XII, L.P.
FHMLS XII, L.L.C. 0.8% 406,246 0 406,246 /s/ Gordon Empey By Gordon Empey, General Counsel of FHMLS XII, L.L.C.
James N. Topper 0.2% 87,424 0 87,424 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
Patrick J. Heron 0.2% 87,424 0 87,424 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
Albert Cha 0% 0 0 0 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Albert Cha, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
James Brush 0% 0 0 0 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for James Brush, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
Daniel Estes 0% 0 0 0 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Daniel Estes, pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .